Anticoagulant Therapy for Venous Thromboembolism in Cancer
- PMID: 32223115
- DOI: 10.1056/NEJMe2004220
Anticoagulant Therapy for Venous Thromboembolism in Cancer
Comment on
-
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Similar articles
-
The best direct-acting oral anticoagulant for treatment of venous thromboembolism?Lancet Haematol. 2019 Jan;6(1):e4-e5. doi: 10.1016/S2352-3026(18)30211-4. Epub 2018 Dec 14. Lancet Haematol. 2019. PMID: 30558986 No abstract available.
-
Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm.Cardiol J. 2020;27(4):347-349. doi: 10.5603/CJ.a2020.0067. Epub 2020 May 18. Cardiol J. 2020. PMID: 32419129 Free PMC article. No abstract available.
-
Direct Oral Anticoagulants for Thromboprophylaxis in Ambulatory Patients with Cancer.N Engl J Med. 2019 Feb 21;380(8):781-783. doi: 10.1056/NEJMe1816060. N Engl J Med. 2019. PMID: 30786193 No abstract available.
-
[Thromboprophylaxis in patients with cancer].Internist (Berl). 2019 Sep;60(9):1004-1006. doi: 10.1007/s00108-019-0647-y. Internist (Berl). 2019. PMID: 31342090 Review. German. No abstract available.
-
[New anticoagulants in the treatment of venous thromboembolism].Rev Prat. 2013 Sep;63(7):980-4. Rev Prat. 2013. PMID: 24167902 Review. French.
Cited by
-
Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review.Rev Cardiovasc Med. 2023 Oct 19;24(10):295. doi: 10.31083/j.rcm2410295. eCollection 2023 Oct. Rev Cardiovasc Med. 2023. PMID: 39077577 Free PMC article. Review.
-
The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts.J Blood Med. 2024 Apr 25;15:171-189. doi: 10.2147/JBM.S411520. eCollection 2024. J Blood Med. 2024. PMID: 38686358 Free PMC article. Review.
-
Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis.Cancers (Basel). 2023 Dec 18;15(24):5887. doi: 10.3390/cancers15245887. Cancers (Basel). 2023. PMID: 38136433 Free PMC article. Review.
-
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism.Curr Oncol Rep. 2023 May;25(5):425-432. doi: 10.1007/s11912-023-01384-7. Epub 2023 Mar 16. Curr Oncol Rep. 2023. PMID: 36928825 Review.
-
Venous thrombosis, multiple carcinomatous foci and differences in metastatic pathways of penile carcinoma.Oncol Lett. 2023 Jan 17;25(3):88. doi: 10.3892/ol.2023.13674. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36817041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources